Literature DB >> 15902528

Synovial nitric oxide concentrations are increased and correlated with serum levels in patients with active Behçet's disease: a pilot study.

Fuat Duygulu1, Cem Evereklioglu, Mustafa Calis, Murat Borlu, Mustafa Cekmen, Ozcan Ascioglu.   

Abstract

Behçet's disease (BD) is a relapsing immunoinflammatory vasculitis of unknown etiology characterized by endothelial dysfunction. Articular symptoms and signs are present in about 75% of cases and characterized by seronegative arthritis and nonspecific synovitis. We demonstrated that both serum and erythrocyte nitric oxide (NO(.)) levels, the most abundant free radical in the body, were elevated in BD and associated with disease activity. This study further investigated NO(.) levels in the synovial fluid and serum from patients with active and inactive BD. A total of 23 BD patients with articular involvement (14 men and 9 women) satisfying International Study Group criteria and 15 age- and sex-matched healthy control subjects (9 men and 6 women) undergoing elective arthroscopy were included in this case-control investigation. The synovial fluid and serum were obtained from BD patients and controls. Clinical and laboratory findings including neutrophil count and erythrocyte sedimentation rate (ESR) were used to classify BD patients as active (n = 11) or inactive (n = 12). Synovial as well as serum NO(.) levels were compared between the groups and correlation analysis was performed. Acute phase reactant levels were significantly higher (for each, p < 0.01) in BD patients than control subjects in the active period. The mean synovial NO(.) level in active Behçet's patients (mean +/- SD 76.61 +/- 11.95 micromol/l) was significantly higher than in inactive patients (46.16 +/- 8.89 micromol/l, p < 0.001) and healthy control subjects (39.60 +/-8.03 micromol/l, p < 0.001). The difference between inactive patients and controls was not significant (p > 0.05). Active BD patients had significantly higher serum NO(.) levels (38.84 +/- 9.15 micromol/l) than inactive patients (30.91 +/- 5.88 micromol/l, p = 0.018) and control subjects (28.86 +/- 5.91 micromol/l, p = 0.002). In addition, synovial NO(.) levels were positively correlated with serum levels (r(2) = 0.621, p < 0.001). Increased synovial NO(.) levels in active BD patients probably reflect a nonspecific inflammatory process of the synovium and, therefore, arthralgia and arthritis as a common finding of BD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15902528     DOI: 10.1007/s10067-004-1015-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  52 in total

Review 1.  Behçet's syndrome.

Authors:  M C Pickering; D O Haskard
Journal:  J R Coll Physicians Lond       Date:  2000 Mar-Apr

2.  Audio-vestibular evaluation in patients with Behçet's syndrome.

Authors:  C Evereklioglu; Y Cokkeser; S Doganay; H Er; A Kizilay
Journal:  J Laryngol Otol       Date:  2001-09       Impact factor: 1.469

3.  Aqueous humor nitric oxide levels in patients with Behçet disease.

Authors:  Gürsel Yilmaz; Sadi Sizmaz; Emine Demirel Yilmaz; Sunay Duman; Pinar Aydin
Journal:  Retina       Date:  2002-06       Impact factor: 4.256

Review 4.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

5.  Characteristics of peripheral arthritis in Behçet's disease.

Authors:  M Calgüneri; S Kíraz; I Ertenli; M Erman; Y Karaarslan; I Celik
Journal:  N Z Med J       Date:  1997-03-14

6.  Thoracic involvement in Behçet's disease and its correlation with multiple parameters.

Authors:  H Gunen; C Evereklioglu; F Kosar; H Er; O Kizkin
Journal:  Lung       Date:  2000       Impact factor: 2.584

7.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.

Authors:  J S Beckman; T W Beckman; J Chen; P A Marshall; B A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

8.  Oxygen radicals and nitric oxide levels in chondral or meniscal lesions or both.

Authors:  Ugur Haklar; Meral Yüksel; Ayliz Velioglu; Metin Turkmen; Gonca Haklar; A Suha Yalçin
Journal:  Clin Orthop Relat Res       Date:  2002-10       Impact factor: 4.176

9.  Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients.

Authors:  I B McInnes; B P Leung; M Field; X Q Wei; F P Huang; R D Sturrock; A Kinninmonth; J Weidner; R Mumford; F Y Liew
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

10.  Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease.

Authors:  Cem Evereklioglu; Hamdi Er; Yusuf Türköz; Mustafa Cekmen
Journal:  Mediators Inflamm       Date:  2002-04       Impact factor: 4.711

View more
  8 in total

Review 1.  Evaluation of current therapeutic strategies in Behçet's disease.

Authors:  Iliana Alexoudi; Violetta Kapsimali; Aristides Vaiopoulos; Meletios Kanakis; George Vaiopoulos
Journal:  Clin Rheumatol       Date:  2010-09-15       Impact factor: 2.980

2.  Prevention of endotoxin-induced uveitis in rats by plant sterol guggulsterone.

Authors:  Nilesh M Kalariya; Mohammad Shoeb; Aramati B M Reddy; Min Zhang; Frederik J G M van Kuijk; Kota V Ramana
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-04-30       Impact factor: 4.799

Review 3.  Outcome measures used in clinical trials for Behçet syndrome: a systematic review.

Authors:  Gulen Hatemi; Peter A Merkel; Vedat Hamuryudan; Maarten Boers; Haner Direskeneli; Sibel Z Aydin; Hasan Yazici
Journal:  J Rheumatol       Date:  2014-02-01       Impact factor: 4.666

4.  Preventive effects of ethyl pyruvate on endotoxin-induced uveitis in rats.

Authors:  Nilesh M Kalariya; Aramati B M Reddy; Naseem H Ansari; Frederik J G M VanKuijk; Kota V Ramana
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-11       Impact factor: 4.799

Review 5.  Behçet syndrome: from pathogenesis to novel therapies.

Authors:  Gianluigi Mazzoccoli; Angela Matarangolo; Rosa Rubino; Michele Inglese; Angelo De Cata
Journal:  Clin Exp Med       Date:  2014-12-02       Impact factor: 3.984

6.  Assessment of serum homocysteine, endothelin-1, and nitric oxide levels in behçet's disease.

Authors:  Abeer A Hodeib; Tarek A Elsharawy; Hisham A Fawzi
Journal:  Indian J Dermatol       Date:  2010 Jul-Sep       Impact factor: 1.494

7.  Aldose reductase inhibition prevents endotoxin-induced uveitis in rats.

Authors:  Umesh C S Yadav; Satish K Srivastava; Kota V Ramana
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-10       Impact factor: 4.799

8.  Ex vivo effects of flavonoïds extracted from Artemisia herba alba on cytokines and nitric oxide production in Algerian patients with Adamantiades-Behçet's disease.

Authors:  Djamel Messaoudene; Houda Belguendouz; Mohamed Laid Ahmedi; Tarek Benabdekader; Fifi Otmani; Malika Terahi; Pierre Youinou; Chafia Touil-Boukoffa
Journal:  J Inflamm (Lond)       Date:  2011-11-21       Impact factor: 4.981

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.